Cassidy, Warner Seek Feedback On Draft Outcome-Based Contract Bill

By Rachel Cohrs / January 29, 2019 at 6:32 PM
Sens. Bill Cassidy (R-LA) and Mark Warner (D-VA) are seeking comments on a draft bill to exempt performance-based drug-reimbursement contracts from the Medicaid best price rule, anti-kickback law and the so-called Stark law against doctor self-referrals, the senators announced Tuesday (Jan. 29). They are seeking input from stakeholders before officially introducing the bill. While the Trump administration and brand-drug industry support outcomes-based contracts, some are skeptical that the practice would have a meaningful impact on prescription drug prices. “We are...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.